Timber Hill’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Timber Hill’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,798	Closed	-$329K	–	803
2017 Q3	$329K	Buy	+3,798	New	+$304K	0.03%	410
2017 Q2	–	Sell	-51,885	Closed	-$3.6M	–	1865
2017 Q1	$3.6M	Buy	51,885 +20,686	+66%	+$1.39M	0.03%	473
2016 Q4	$1.85M	Buy	+31,199	New	+$1.93M	0.01%	957
2016 Q3	–	Sell	-109,434	Closed	-$5.92M	–	2266
2016 Q2	$5.92M	Buy	109,434 +75,513	+223%	+$4.14M	0.03%	475
2016 Q1	$1.75M	Sell	33,921 -64,257	-65%	-$3.34M	0.01%	999
2015 Q4	$6.89M	Sell	98,178 -9,145	-9%	-$624K	0.03%	432
2015 Q3	$6.68M	Sell	107,323 -106,514	-50%	-$8.39M	0.03%	453
2015 Q2	$18M	Buy	213,837 +203,889	+2,050%	+$15.9M	0.08%	213
2015 Q1	$748K	Sell	9,948 -18,183	-65%	-$1.27M	﹤0.01%	1587
2014 Q4	$1.75M	Sell	28,131 -33,516	-54%	-$1.91M	0.01%	1101
2014 Q3	$3.21M	Sell	61,647 -96,087	-61%	-$4.9M	0.01%	847
2014 Q2	$8.1M	Buy	+157,734	New	+$7.11M	0.04%	408

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Timber Hill's XBI Position: Q4 2017 in Review

Timber Hill sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 3,798 shares — an estimated $329K sold.

Timber Hill first reported a position in XBI in Q2 2014 and held it in 12 quarters. The position peaked at $18M in Q2 2015. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

Timber Hill reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
Timber Hill sold 3,798 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $329K.
Timber Hill first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and held it in 12 quarters.
Timber Hill's State Street SPDR S&P Biotech ETF position peaked at $18M in Q2 2015.
397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.